← Open Payments lookup

KEVIN HUANG: Open Payments

NPI 1831378975 · PHILA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,825 in 75 payments from 10 companies in 2025. Trend: 2023 $2,031 · 2024 $2,385 · 2025 $3,825

Food & beverage: $3,714Education: $111
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.16$813
Janssen Pharmaceuticals, Inc14$726
Otsuka America Pharmaceutical, Inc.7$568
E.R. Squibb & Sons, L.L.C.9$476
Janssen Scientific Affairs, LLC3$360
ABBVIE INC.9$262
Neurocrine BioSciences, Inc.5$210
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$195
Alkermes, Inc.4$154
Lundbeck LLC3$60

Products named: INVEGA SUSTENNA, UZEDY, COBENFY, REXULTI, ABILIFY MAINTENA, VRAYLAR, INGREZZA, CAPLYTA.

Industry payments across PA — which companies pay providers there.